bioMérieux Stock Euronext Paris
Stocks
FR0010096479
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 8.59B 9.91B 8.05B 7.34B 13.82B 946B 14.04B 94.83B 37.02B 474B 37.21B 36.41B 1,580B | P/E 2026 * |
17.9x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.18B 9.44B 7.67B 7B 13.16B 901B 13.37B 90.33B 35.27B 451B 35.45B 34.68B 1,505B | EV / Sales 2026 * |
1.98x | EV / Sales 2027 * | 1.81x |
| Free-Float |
33.22% | Yield 2026 * |
1.43% | Yield 2027 * | 1.58% |
Last Transcript: bioMérieux
| 1 day | -0.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 53 | 2023-06-30 |
| Director of Finance/CFO | 50 | 2018-02-28 | |
| Chief Tech/Sci/R&D Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 2017-12-14 | |
| Director/Board Member | 66 | 2004-12-31 | |
| Director/Board Member | 61 | 2012-05-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.25% | - | - | 9.92B | |
| -3.33% | +1.52% | +173.14% | +346.75% | 22.16B | |
| -0.07% | +1.53% | -41.65% | -22.29% | 9.92B | |
| +1.73% | +27.85% | +329.62% | +16.32% | 7.52B | |
| +0.19% | -0.14% | +87.63% | +46.18% | 6.57B | |
| -0.47% | +11.65% | -34.86% | - | 6.29B | |
| +3.40% | +6.64% | -13.52% | -9.97% | 5.59B | |
| +0.88% | +3.82% | +80.65% | +102.55% | 4.46B | |
| +1.16% | -0.03% | -8.99% | -18.14% | 4.23B | |
| +0.25% | -0.80% | -23.37% | -35.60% | 2.74B | |
| Average | +0.45% | +6.69% | +60.96% | +53.22% | 7.72B | |
| Weighted average by Cap. | -0.35% | +6.20% | +92.70% | +128.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.12B 4.76B 3.87B 3.53B 6.63B 454B 6.74B 45.52B 17.77B 227B 17.86B 17.48B 758B | 4.34B 5B 4.07B 3.71B 6.98B 478B 7.09B 47.88B 18.69B 239B 18.79B 18.38B 798B |
| Net income | 482M 557M 452M 412M 776M 53.11B 788M 5.32B 2.08B 26.59B 2.09B 2.04B 88.69B | 525M 606M 492M 449M 845M 57.84B 858M 5.8B 2.26B 28.95B 2.28B 2.23B 96.58B |
| Net Debt | -408M -470M -382M -348M -656M -44.89B -666M -4.5B -1.76B -22.47B -1.77B -1.73B -74.96B | -731M -844M -685M -625M -1.18B -80.51B -1.19B -8.07B -3.15B -40.3B -3.17B -3.1B -134B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
